Biotech

All Articles

8 months after a $213M fundraise, gene publisher Tome produces reduces

.After rearing $213 thousand in 2023-- one of the year's largest exclusive biotech rounds-- Tome Bio...

BioMarin constructs exec crew with biotech veterinarians-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shootin...

Biopharma Q2 VC hit highest degree because '22, while M&ampA slowed

.Financial backing backing right into biopharma cheered $9.2 billion throughout 215 deals in the sec...

Bicara, Zenas seek IPOs to push late-phase properties towards market

.Bicara Rehabs and Zenas Biopharma have offered fresh impetus to the IPO market along with filings t...

Genentech to close cancer cells immunology analysis department

.Genentech is going to shut its own cancer cells immunology analysis division, as well as system hea...

Kezar loses sound cyst but to verify its own worth in phase 1 trial

.Kezar Lifestyle Sciences is actually dropping its own unpromising period 1 solid lump medication as...

Acelyrin goes down izokibep, lets go 3rd of staff

.Despite izokibep maintaining its own newfound winning touch in the facility, Acelyrin is actually n...

Rivus' stage 2 obesity-related heart failure trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing medicati...

Ovid halts preclinical work, IV system after soticlestat fail

.Ovid Rehab currently showed final month that it was actually trimming its headcount as the provider...

Eli Lilly opens up $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has actually opened a $700 million R&ampD facility in the Boston Port, boosting its own R...